Quest Diagnostics revenue and financials
$228.39Change from previous close: −1.65%Absolute change: −$3.83
In the fiscal year ended December 2025, Quest Diagnostics reported revenue of $11.04B (+11.78% year over year). Net income was $992M, a net margin of 9.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +11.78%
- 2025 vs 2024
- Net income growth
- +13.89%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 8.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,886 | 1,334 | 1,272 | 1,718 | 2,233 | 2,005 | 1,243 | 1,200 | 1,175 | 1,116 |
| Depreciation and amortization | 570 | 493 | 439 | 437 | 408 | 361 | 329 | 309 | 270 | 249 |
| Capital expenditure | -527 | -425 | -408 | -404 | -403 | -418 | -400 | -383 | -252 | -293 |
| Investing cash flow | -631 | -2,548 | -1,061 | -543 | 21.0 | — | — | — | — | — |
| Financing cash flow | -1,388 | 1,084 | 160 | -1,732 | -2,540 | — | — | — | — | — |
| Dividends paid | -353 | -331 | -314 | -305 | -309 | -297 | -286 | -266 | -247 | -223 |
| Share repurchases | -450 | -151 | -275 | -1,408 | -2,199 | -325 | -353 | -322 | -465 | -590 |
| Debt issued | 410 | 1,846 | 2,592 | 0.0 | — | — | — | — | — | — |
| Debt repaid | -1,012 | -303 | -1,844 | -2.0 | — | — | — | — | — | — |
| Effect of exchange rates | 4.0 | -7.0 | 0.0 | 0.0 | — | — | — | — | — | — |
| Net change in cash | -129 | -137 | 371 | -557 | -286 | — | — | — | — | — |
| Free cash flow | 1,359 | 909 | 864 | 1,314 | 1,830 | — | — | — | — | — |
| Levered free cash flow | 1,011 | 744 | 652 | 1,015 | 1,564 | — | — | — | — | — |